Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system

Sarka Varcabova, Zuzana Huskova, Herbert J. Kramer, Sung Hee Hwang, Bruce D. Hammock, John D. Imig, Kento Kitada, Ludek Cervenka

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of the present study was to evaluate the hypothesis that the antihypertensive effects of inhibition of soluble epoxide hydrolase (sEH) are mediated by increased intrarenal availability of epoxyeicosatrienoic acids (EETs), with consequent improvement in renal haemodynamic autoregulatory efficiency and the pressure-natriuresis relationship. Ren-2 transgenic rats (TGR), a model of angiotensin (Ang) II-dependent hypertension, and normotensive transgene-negative Hannover Sprague-Dawley (HanSD) rats were treated with the sEH inhibitor cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy)benzoic acid (c-AUCB; 26 mg/L) for 48 h. Then, the effects on blood pressure (BP), autoregulation of renal blood flow (RBF) and glomerular filtration rate (GFR), and on the pressure-natriuresis relationship in response to stepwise reductions in renal arterial pressure (RAP) were determined. Treatment with c-AUCB did not significantly change BP, renal autoregulation or pressure-natriuresis in normotensive HanSD rats. In contrast, c-AUCB treatment significantly reduced BP, increased intrarenal bioavailability of EETs and significantly suppressed AngII levels in TGR. However, treatment with c-AUCB did not significantly improve the autoregulatory efficiency of RBF and GFR in response to reductions of RAP and to restore the blunted pressure-natriuresis relationship in TGR. Together, the data indicate that the antihypertensive actions of sEH inhibition in TGR are predominantly mediated via significant suppression of intrarenal renin-angiotensin system activity.

Original languageEnglish (US)
Pages (from-to)273-281
Number of pages9
JournalClinical and Experimental Pharmacology and Physiology
Volume40
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Transgenic Rats
Epoxide Hydrolases
Natriuresis
Renin-Angiotensin System
Antihypertensive Agents
Kidney
Pressure
Renal Circulation
Blood Pressure
Glomerular Filtration Rate
Sprague Dawley Rats
Arterial Pressure
Homeostasis
Benzoic Acid
Transgenes
Angiotensin II
Biological Availability
Hemodynamics
Hypertension
Acids

Keywords

  • Cytochrome P450 metabolites
  • Epoxyeicosatrienoic acids
  • Glomerular filtration rate
  • Hypertension
  • Pressure-natriuresis
  • Renal blood flow
  • Renin-angiotensin system
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Pharmacology

Cite this

Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system. / Varcabova, Sarka; Huskova, Zuzana; Kramer, Herbert J.; Hwang, Sung Hee; Hammock, Bruce D.; Imig, John D.; Kitada, Kento; Cervenka, Ludek.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 40, No. 4, 04.2013, p. 273-281.

Research output: Contribution to journalArticle

Varcabova, Sarka ; Huskova, Zuzana ; Kramer, Herbert J. ; Hwang, Sung Hee ; Hammock, Bruce D. ; Imig, John D. ; Kitada, Kento ; Cervenka, Ludek. / Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system. In: Clinical and Experimental Pharmacology and Physiology. 2013 ; Vol. 40, No. 4. pp. 273-281.
@article{5ba3aae4acb64230ada6abf93c5d85d9,
title = "Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system",
abstract = "The aim of the present study was to evaluate the hypothesis that the antihypertensive effects of inhibition of soluble epoxide hydrolase (sEH) are mediated by increased intrarenal availability of epoxyeicosatrienoic acids (EETs), with consequent improvement in renal haemodynamic autoregulatory efficiency and the pressure-natriuresis relationship. Ren-2 transgenic rats (TGR), a model of angiotensin (Ang) II-dependent hypertension, and normotensive transgene-negative Hannover Sprague-Dawley (HanSD) rats were treated with the sEH inhibitor cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy)benzoic acid (c-AUCB; 26 mg/L) for 48 h. Then, the effects on blood pressure (BP), autoregulation of renal blood flow (RBF) and glomerular filtration rate (GFR), and on the pressure-natriuresis relationship in response to stepwise reductions in renal arterial pressure (RAP) were determined. Treatment with c-AUCB did not significantly change BP, renal autoregulation or pressure-natriuresis in normotensive HanSD rats. In contrast, c-AUCB treatment significantly reduced BP, increased intrarenal bioavailability of EETs and significantly suppressed AngII levels in TGR. However, treatment with c-AUCB did not significantly improve the autoregulatory efficiency of RBF and GFR in response to reductions of RAP and to restore the blunted pressure-natriuresis relationship in TGR. Together, the data indicate that the antihypertensive actions of sEH inhibition in TGR are predominantly mediated via significant suppression of intrarenal renin-angiotensin system activity.",
keywords = "Cytochrome P450 metabolites, Epoxyeicosatrienoic acids, Glomerular filtration rate, Hypertension, Pressure-natriuresis, Renal blood flow, Renin-angiotensin system, Soluble epoxide hydrolase",
author = "Sarka Varcabova and Zuzana Huskova and Kramer, {Herbert J.} and Hwang, {Sung Hee} and Hammock, {Bruce D.} and Imig, {John D.} and Kento Kitada and Ludek Cervenka",
year = "2013",
month = "4",
doi = "10.1111/1440-1681.12018",
language = "English (US)",
volume = "40",
pages = "273--281",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system

AU - Varcabova, Sarka

AU - Huskova, Zuzana

AU - Kramer, Herbert J.

AU - Hwang, Sung Hee

AU - Hammock, Bruce D.

AU - Imig, John D.

AU - Kitada, Kento

AU - Cervenka, Ludek

PY - 2013/4

Y1 - 2013/4

N2 - The aim of the present study was to evaluate the hypothesis that the antihypertensive effects of inhibition of soluble epoxide hydrolase (sEH) are mediated by increased intrarenal availability of epoxyeicosatrienoic acids (EETs), with consequent improvement in renal haemodynamic autoregulatory efficiency and the pressure-natriuresis relationship. Ren-2 transgenic rats (TGR), a model of angiotensin (Ang) II-dependent hypertension, and normotensive transgene-negative Hannover Sprague-Dawley (HanSD) rats were treated with the sEH inhibitor cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy)benzoic acid (c-AUCB; 26 mg/L) for 48 h. Then, the effects on blood pressure (BP), autoregulation of renal blood flow (RBF) and glomerular filtration rate (GFR), and on the pressure-natriuresis relationship in response to stepwise reductions in renal arterial pressure (RAP) were determined. Treatment with c-AUCB did not significantly change BP, renal autoregulation or pressure-natriuresis in normotensive HanSD rats. In contrast, c-AUCB treatment significantly reduced BP, increased intrarenal bioavailability of EETs and significantly suppressed AngII levels in TGR. However, treatment with c-AUCB did not significantly improve the autoregulatory efficiency of RBF and GFR in response to reductions of RAP and to restore the blunted pressure-natriuresis relationship in TGR. Together, the data indicate that the antihypertensive actions of sEH inhibition in TGR are predominantly mediated via significant suppression of intrarenal renin-angiotensin system activity.

AB - The aim of the present study was to evaluate the hypothesis that the antihypertensive effects of inhibition of soluble epoxide hydrolase (sEH) are mediated by increased intrarenal availability of epoxyeicosatrienoic acids (EETs), with consequent improvement in renal haemodynamic autoregulatory efficiency and the pressure-natriuresis relationship. Ren-2 transgenic rats (TGR), a model of angiotensin (Ang) II-dependent hypertension, and normotensive transgene-negative Hannover Sprague-Dawley (HanSD) rats were treated with the sEH inhibitor cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy)benzoic acid (c-AUCB; 26 mg/L) for 48 h. Then, the effects on blood pressure (BP), autoregulation of renal blood flow (RBF) and glomerular filtration rate (GFR), and on the pressure-natriuresis relationship in response to stepwise reductions in renal arterial pressure (RAP) were determined. Treatment with c-AUCB did not significantly change BP, renal autoregulation or pressure-natriuresis in normotensive HanSD rats. In contrast, c-AUCB treatment significantly reduced BP, increased intrarenal bioavailability of EETs and significantly suppressed AngII levels in TGR. However, treatment with c-AUCB did not significantly improve the autoregulatory efficiency of RBF and GFR in response to reductions of RAP and to restore the blunted pressure-natriuresis relationship in TGR. Together, the data indicate that the antihypertensive actions of sEH inhibition in TGR are predominantly mediated via significant suppression of intrarenal renin-angiotensin system activity.

KW - Cytochrome P450 metabolites

KW - Epoxyeicosatrienoic acids

KW - Glomerular filtration rate

KW - Hypertension

KW - Pressure-natriuresis

KW - Renal blood flow

KW - Renin-angiotensin system

KW - Soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=84875652885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875652885&partnerID=8YFLogxK

U2 - 10.1111/1440-1681.12018

DO - 10.1111/1440-1681.12018

M3 - Article

C2 - 23039246

AN - SCOPUS:84875652885

VL - 40

SP - 273

EP - 281

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 4

ER -